Adma Biologics (ADMA) Raw Materials (2016 - 2026)
Adma Biologics' Raw Materials came in at $94.3 million for Q2 2026, down 6.1% from $100.37 million a year earlier but up 5.6% from the prior quarter.
Analysis
Adma Biologics (ADMA) Raw Materials (2016 - 2026) Analysis & Trends
At the end of FY2025, Adma Biologics' Raw Materials was $96.61 million, up 59.8% from FY2024.
- Raw Materials has increased in each of the last five years, with a five-year compound annual growth rate of 24.7% (FY2020 to FY2025).
- Going back by year, Raw Materials was $60.47 million in FY2024 (+14.1%), $53 million in FY2023 (+9.0%), $48.64 million in FY2022 (+32.3%) and $36.76 million in FY2021 (+14.7%).
- The five-year range for quarterly Raw Materials is $36.76 million (Q4 2021) to $100.37 million (Q2 2025).
- Year-over-year, Raw Materials increased in seven of the last eight quarters, with growth averaging 32.4%.
- The fastest year-over-year change in Raw Materials over five years came in Q2 2025 (growth of 76.1%), and the weakest in Q2 2026 (a decline of 6.1%).
- Business Quant data shows ADMA's Raw Materials at $89.28 million (Q1 2026), $96.61 million (Q4 2025) and $87.84 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Adma Biologics | 2.28 Bn | 1.86 Bn | 86.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 94.30 Mn |
| Mar 31, 2026 | 89.28 Mn |
| Dec 31, 2025 | 96.61 Mn |
| Sep 30, 2025 | 87.84 Mn |
| Jun 30, 2025 | 100.37 Mn |
| Mar 31, 2025 | 75.82 Mn |
| Dec 31, 2024 | 60.47 Mn |
| Sep 30, 2024 | 55.25 Mn |
| Jun 30, 2024 | 56.99 Mn |
| Mar 31, 2024 | 59.46 Mn |
| Dec 31, 2023 | 53.00 Mn |
| Sep 30, 2023 | 49.86 Mn |
| Jun 30, 2023 | 50.00 Mn |
| Mar 31, 2023 | 55.75 Mn |
| Dec 31, 2022 | 48.64 Mn |
| Sep 30, 2022 | 47.78 Mn |
| Jun 30, 2022 | 38.32 Mn |
| Mar 31, 2022 | 46.03 Mn |
| Dec 31, 2021 | 36.76 Mn |
| Sep 30, 2021 | 37.93 Mn |
API Access
Adma Biologics Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=ADMA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();